Trials / Unknown
UnknownNCT02148848
Short-term Functional Recovery Between Early- and Late Bisphosphonate Treatment Following Hemiarthroplasty
A Comparative Study of Short-term Functional Recovery Between Early- and Late Bisphosphonate Treatment Following Hemiarthroplasty in Patients With Osteoporotic Femoral Neck Fractures
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 86 (estimated)
- Sponsor
- Mahidol University · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Femoral neck fracture in the elderly is one indication for initiating osteoporosis treatment. Bisphosphonates remain the first line therapy; however, many orthopaedic surgeons concern regarding their effects on fracture healing process. Therefore, therapy is usually delayed for a period of time. To the best of our knowledge, there is no scientific data to support whether bisphosphonate treatment should be given immediately after the surgery or it should be delayed.
Detailed description
Femoral neck fracture in the elderly is one indication for initiating osteoporosis treatment. Bisphosphonates remain the first line therapy; however, many orthopaedic surgeons concern regarding their effects on fracture healing process. Therefore, therapy is usually delayed for a period of time. To the best of our knowledge, there is no scientific data to support whether bisphosphonate treatment should be given immediately after the surgery or it should be delayed. This study aims to compare functional recovery between early- and late administration of bisphosphonate in patients who received hemiarthroplasty following femoral neck fractures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Risedronate | Take risedronate 35 mg orally every week |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2017-10-01
- Completion
- 2017-10-01
- First posted
- 2014-05-28
- Last updated
- 2016-09-14
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT02148848. Inclusion in this directory is not an endorsement.